vitamin k 3 has been researched along with Ischemia in 1 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, Y | 1 |
| Sakai, H | 1 |
| Kohiki, E | 1 |
| Suga, E | 1 |
| Yanagisawa, Y | 1 |
| Tanaka, K | 1 |
| Hadano, S | 1 |
| Osuga, H | 1 |
| Ikeda, JE | 1 |
1 other study available for vitamin k 3 and Ischemia
| Article | Year |
|---|---|
A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein.
Topics: Animals; Apoptosis; Cell Line; Dopamine D2 Receptor Antagonists; Drug Evaluation, Preclinical; Enzym | 2005 |